Tag: SRMX

Blue Horseshoe Stocks: AAPL Options & More

Lumber Liquidators Holdings Inc. LL – Recap
Although LL did gap up a lot higher than expected to start the session, and larger gains would have been available at higher strike prices closer to the money, but most of our listed targets, the LL Weekly $27.50-29.50 Calls, still managed to see some solid intraday moves.

Those potential gains, including a double-bagger by the $28’s, were as follows:

$27.50 Calls – Range: 3.00-5.50 – Max Gain: 83%
$28 Calls – Range: 2.30-5.00 – Max Gain: 117%
$28.50 Calls – Range: 3.36-4.27 – Max Gain: 27%
$29 Calls – Range: 2.00-3.70 – Max Gain: 85%

Apple, Inc. AAPL

With AAPL breaking out to new all-time highs in the premarket this morning, after a strong earnings report was more than enough to assuage any concerns about lagging iPhone sales, we’re going to want to try to get in on the fun.

AAPL is gearing up to the point that it may also drive the DOW to the 22,000 level, causing a cascading effect that should make for an interesting week for traders across the board.

As for us, we’re going to be tracking the AAPL Weekly $155-162.50 Calls on the heels of this premarket mega-push that has thus far yielded a high of $160 on the nose.

Amarin Corp plc AMRN

We also want to take note of AMRN, which recently took a fair beating on the chart, and is showing clear signs of a reversal.

We also want to signal some calls in that options chain as well as watching the stock itself. The AMRN Weekly $4 Calls will be the options we put on our radar.

Extended Watchlist:
SRMX, STBV, RWLK, CLSN, CLDX, OGXI, MTW

Blue Horseshoe Stocks: WFM Followup, ZSAN & More

Whole Foods Market, Inc. WFM – Options Update

Our primary focus for yesterday morning’s premarket report was our running options idea from last week. We were mentioning that the WFM 02/17 $30 and 30.50 Calls had begun to heat up, and we didn’t want to miss out on the activity that seemed ready to kick our idea into effect.

Our assumptions turned out to be accurate, with WFM stringing on another good session performance. The $30 Calls traded up from a low of .54 to .90 (+66%), while the $30.50’s made their way from .20-.42 (+110%).

We also mentioned that a break of the 50DMA at 30.76 for WFM would prompt us to look at contracts with a higher strike price and later expiration, the WFM 02/24 $31 Calls. We did indeed witness a breach of that price point toward the end of the session, and those calls came into play as well, running from 20-.35 for a chance at a nice 75% gain.

Should the solid uptrend WFM has been putting together continue into future sessions, these could be an ongoing item of interest for us.

Zosano Pharma Corp. ZSAN

ZSAN is a play we highlighted on Monday after the company reported that in its ZOTRIP pivotal efficacy study, its M207 transdermal migraine therapy patch met both primary, as well as secondary endpoints.

We mentioned that not only were we going to experience the effect of positive study data, but a technically ripening chart as well, leading us to put the stock on high alert in coming sessions.

It was a good decision, as the stock has really gained momentum this week, putting together some solid sessions. In fact, yesterday the stock closed as the NASDAQ’s top gainer of the day. We’ve watched as ZSAN has traded up from a low of 1.65 to yesterday’s new high of 3.49, representing an intraweek upswing of 112% Cheers to those of our readers who came along for the ride!


Opko Health, Inc. OPK

We put OPK on bottom watch earlier this month, and after a few sessions of further consolidation, the past four trading days have shown some convincing bottom-bounce action.

The stock ultimately found support at the 7.99-level last week, from which it has logged five straight sessions of higher highs and higher lows, reaching 8.66 yesterday. While that action only equates to an 8% increase, it’s the massive gap on the chart to the upside from just under $10 to just over $11.50. We’ll look for the stock to continue to build gradually and maintain the current trend in hopes of seeing a run toward a gap-fill.

FRESH OPTIONS IDEA:

Kate Spade & Co. KATE Weekly $20 and $21 Calls

Extended Watchlist:
RSII, MAXD, SRMX, CLSN, TPX